

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA unwinding involved in DNA replication (GO:0006268) | 5.28294700 |
| 2 | ribosomal small subunit assembly (GO:0000028) | 5.17612586 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.03844967 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.03844967 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.54836992 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.41741639 |
| 7 | proteasome assembly (GO:0043248) | 4.40787283 |
| 8 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.29046391 |
| 9 | ribosome assembly (GO:0042255) | 4.28872566 |
| 10 | viral transcription (GO:0019083) | 4.12283536 |
| 11 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.08495507 |
| 12 | DNA strand elongation (GO:0022616) | 4.07913805 |
| 13 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.02265984 |
| 14 | translational termination (GO:0006415) | 4.01217863 |
| 15 | CENP-A containing nucleosome assembly (GO:0034080) | 3.94269705 |
| 16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.93368940 |
| 17 | chromatin remodeling at centromere (GO:0031055) | 3.81339550 |
| 18 | purine nucleobase biosynthetic process (GO:0009113) | 3.80382533 |
| 19 | DNA replication checkpoint (GO:0000076) | 3.76107694 |
| 20 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.71512931 |
| 21 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.68685857 |
| 22 | DNA replication initiation (GO:0006270) | 3.63755827 |
| 23 | translational elongation (GO:0006414) | 3.62080747 |
| 24 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.62076798 |
| 25 | non-recombinational repair (GO:0000726) | 3.61111400 |
| 26 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.61111400 |
| 27 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.58989102 |
| 28 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.57877787 |
| 29 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.53731277 |
| 30 | regulation of gamma-delta T cell activation (GO:0046643) | 3.53478497 |
| 31 | protein localization to kinetochore (GO:0034501) | 3.51700021 |
| 32 | telomere maintenance via recombination (GO:0000722) | 3.50976168 |
| 33 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.49170316 |
| 34 | mitotic recombination (GO:0006312) | 3.48099842 |
| 35 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.44541876 |
| 36 | IMP biosynthetic process (GO:0006188) | 3.38923825 |
| 37 | ribosomal small subunit biogenesis (GO:0042274) | 3.37911641 |
| 38 | protein K6-linked ubiquitination (GO:0085020) | 3.37397865 |
| 39 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.36618331 |
| 40 | negative regulation of ligase activity (GO:0051352) | 3.36618331 |
| 41 | cotranslational protein targeting to membrane (GO:0006613) | 3.36125577 |
| 42 | protein targeting to ER (GO:0045047) | 3.35388741 |
| 43 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.35212756 |
| 44 | histone exchange (GO:0043486) | 3.34755086 |
| 45 | V(D)J recombination (GO:0033151) | 3.34164662 |
| 46 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.33070324 |
| 47 | G1/S transition of mitotic cell cycle (GO:0000082) | 3.26391350 |
| 48 | cell cycle G1/S phase transition (GO:0044843) | 3.26391350 |
| 49 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.26137787 |
| 50 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.25394368 |
| 51 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.25394368 |
| 52 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.25394368 |
| 53 | maturation of SSU-rRNA (GO:0030490) | 3.25241833 |
| 54 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 3.24062802 |
| 55 | isotype switching (GO:0045190) | 3.24062802 |
| 56 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 3.24062802 |
| 57 | pore complex assembly (GO:0046931) | 3.24007120 |
| 58 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.23685634 |
| 59 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.23685634 |
| 60 | DNA duplex unwinding (GO:0032508) | 3.23609800 |
| 61 | DNA geometric change (GO:0032392) | 3.23401486 |
| 62 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.22161729 |
| 63 | IMP metabolic process (GO:0046040) | 3.21871766 |
| 64 | B cell receptor signaling pathway (GO:0050853) | 3.21077864 |
| 65 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.19817126 |
| 66 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.19817126 |
| 67 | positive regulation of B cell differentiation (GO:0045579) | 3.19764943 |
| 68 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.19139323 |
| 69 | negative regulation of phagocytosis (GO:0050765) | 3.17485947 |
| 70 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.15852694 |
| 71 | translesion synthesis (GO:0019985) | 3.14954668 |
| 72 | mitotic chromosome condensation (GO:0007076) | 3.12395963 |
| 73 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.11889840 |
| 74 | cellular protein complex disassembly (GO:0043624) | 3.11853880 |
| 75 | translational initiation (GO:0006413) | 3.11832884 |
| 76 | protein localization to endoplasmic reticulum (GO:0070972) | 3.11532958 |
| 77 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.11310643 |
| 78 | synapsis (GO:0007129) | 3.10658118 |
| 79 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.09946969 |
| 80 | viral life cycle (GO:0019058) | 3.08727027 |
| 81 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.08411963 |
| 82 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.08050242 |
| 83 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.07634979 |
| 84 | regulation of translational termination (GO:0006449) | 3.07596367 |
| 85 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.06347295 |
| 86 | tetrahydrofolate metabolic process (GO:0046653) | 3.04414418 |
| 87 | telomere maintenance via telomere lengthening (GO:0010833) | 3.03643386 |
| 88 | rRNA modification (GO:0000154) | 3.03027702 |
| 89 | DNA ligation (GO:0006266) | 3.02315173 |
| 90 | positive regulation of ligase activity (GO:0051351) | 3.01262372 |
| 91 | mitotic metaphase plate congression (GO:0007080) | 3.00472594 |
| 92 | negative T cell selection (GO:0043383) | 3.00448157 |
| 93 | protein localization to chromosome, centromeric region (GO:0071459) | 2.99484934 |
| 94 | regulation of centriole replication (GO:0046599) | 2.95521889 |
| 95 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.93041585 |
| 96 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.93041585 |
| 97 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.92941575 |
| 98 | somatic cell DNA recombination (GO:0016444) | 2.92831048 |
| 99 | somatic diversification of immune receptors via germline recombination within a single locus (GO:000 | 2.92831048 |
| 100 | formation of translation preinitiation complex (GO:0001731) | 2.92602065 |
| 101 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.91883389 |
| 102 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.91883389 |
| 103 | mitotic nuclear envelope disassembly (GO:0007077) | 2.91423162 |
| 104 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.91421674 |
| 105 | DNA replication-independent nucleosome organization (GO:0034724) | 2.91421674 |
| 106 | regulation of DNA endoreduplication (GO:0032875) | 2.91209643 |
| 107 | maturation of 5.8S rRNA (GO:0000460) | 2.90944152 |
| 108 | mitotic sister chromatid cohesion (GO:0007064) | 2.90902238 |
| 109 | kinetochore organization (GO:0051383) | 2.90748005 |
| 110 | cullin deneddylation (GO:0010388) | 2.89849757 |
| 111 | metaphase plate congression (GO:0051310) | 2.88991033 |
| 112 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.87891911 |
| 113 | protein complex disassembly (GO:0043241) | 2.87406202 |
| 114 | regulation of B cell differentiation (GO:0045577) | 2.86527559 |
| 115 | somatic recombination of immunoglobulin gene segments (GO:0016447) | 2.85585491 |
| 116 | DNA double-strand break processing (GO:0000729) | 2.84844259 |
| 117 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.84646461 |
| 118 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.84207223 |
| 119 | replication fork processing (GO:0031297) | 2.82235347 |
| 120 | regulation of ligase activity (GO:0051340) | 2.81335958 |
| 121 | sister chromatid segregation (GO:0000819) | 2.81150991 |
| 122 | nuclear pore organization (GO:0006999) | 2.80278358 |
| 123 | DNA topological change (GO:0006265) | 2.80231066 |
| 124 | positive regulation of chromosome segregation (GO:0051984) | 2.79701165 |
| 125 | protein deneddylation (GO:0000338) | 2.79357996 |
| 126 | chromosome segregation (GO:0007059) | 2.78775647 |
| 127 | nuclear pore complex assembly (GO:0051292) | 2.77561790 |
| 128 | tRNA aminoacylation for protein translation (GO:0006418) | 2.77547674 |
| 129 | somatic diversification of immune receptors (GO:0002200) | 2.76128904 |
| 130 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.74515640 |
| 131 | cellular hyperosmotic response (GO:0071474) | 2.73996678 |
| 132 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.70476552 |
| 133 | ribosomal large subunit biogenesis (GO:0042273) | 2.70357105 |
| 134 | nucleobase biosynthetic process (GO:0046112) | 2.67142805 |
| 135 | T cell homeostasis (GO:0043029) | 2.66128115 |
| 136 | membrane disassembly (GO:0030397) | 2.65987629 |
| 137 | nuclear envelope disassembly (GO:0051081) | 2.65987629 |
| 138 | macromolecular complex disassembly (GO:0032984) | 2.65955255 |
| 139 | hepatocyte apoptotic process (GO:0097284) | 2.65918312 |
| 140 | positive thymic T cell selection (GO:0045059) | 2.65801386 |
| 141 | negative regulation of RNA splicing (GO:0033119) | 2.65680474 |
| 142 | mitotic sister chromatid segregation (GO:0000070) | 2.63970512 |
| 143 | negative thymic T cell selection (GO:0045060) | 2.63197429 |
| 144 | telomere maintenance (GO:0000723) | 2.62845985 |
| 145 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.60895524 |
| 146 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.60895524 |
| 147 | mast cell activation (GO:0045576) | 2.60869797 |
| 148 | establishment of integrated proviral latency (GO:0075713) | 2.60686332 |
| 149 | telomere organization (GO:0032200) | 2.59870003 |
| 150 | postreplication repair (GO:0006301) | 2.57904407 |
| 151 | DNA conformation change (GO:0071103) | 2.56747221 |
| 152 | mRNA catabolic process (GO:0006402) | 2.56523176 |
| 153 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.56119780 |
| 154 | positive T cell selection (GO:0043368) | 2.51446767 |
| 155 | angiogenesis involved in wound healing (GO:0060055) | 2.50682813 |
| 156 | B cell mediated immunity (GO:0019724) | 2.50658339 |
| 157 | RNA catabolic process (GO:0006401) | 2.50547157 |
| 158 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.49374658 |
| 159 | cellular response to zinc ion (GO:0071294) | 2.48351652 |
| 160 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.48053042 |
| 161 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.48053042 |
| 162 | dosage compensation (GO:0007549) | 2.47583072 |
| 163 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.46194649 |
| 164 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.46099537 |
| 165 | T cell apoptotic process (GO:0070231) | 2.45637880 |
| 166 | definitive hemopoiesis (GO:0060216) | 2.43467425 |
| 167 | positive regulation of lamellipodium assembly (GO:0010592) | 2.42949273 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 9.16749782 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.78862913 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.52890654 |
| 4 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.21186778 |
| 5 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.10163449 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.04698011 |
| 7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.98579486 |
| 8 | MYC_22102868_ChIP-Seq_BL_Human | 2.80832356 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.66806802 |
| 10 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.53070183 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.42884725 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.35167174 |
| 13 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.25028296 |
| 14 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.19467017 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.15699141 |
| 16 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.11645477 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.11249712 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.03100470 |
| 19 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.96519833 |
| 20 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.95186985 |
| 21 | MYB_26560356_Chip-Seq_TH2_Human | 1.91130805 |
| 22 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.90362214 |
| 23 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.90216692 |
| 24 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.90193379 |
| 25 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.88447747 |
| 26 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87280068 |
| 27 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.86875079 |
| 28 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.83104336 |
| 29 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.79192350 |
| 30 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.78647012 |
| 31 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.78283470 |
| 32 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.76462959 |
| 33 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.74817013 |
| 34 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.74757244 |
| 35 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.73553583 |
| 36 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.73043949 |
| 37 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.72958600 |
| 38 | MAF_26560356_Chip-Seq_TH1_Human | 1.68512446 |
| 39 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.66864944 |
| 40 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.64608671 |
| 41 | MYB_26560356_Chip-Seq_TH1_Human | 1.64152706 |
| 42 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.64133119 |
| 43 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.62535255 |
| 44 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.62334116 |
| 45 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.62223260 |
| 46 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.60463067 |
| 47 | GATA1_22025678_ChIP-Seq_K562_Human | 1.59082963 |
| 48 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.58774862 |
| 49 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.55276602 |
| 50 | UTX_26944678_Chip-Seq_JUKART_Human | 1.53630210 |
| 51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52371247 |
| 52 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52295267 |
| 53 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.50535354 |
| 54 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.50183620 |
| 55 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.49616452 |
| 56 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.48758081 |
| 57 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.48596670 |
| 58 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.46951520 |
| 59 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.46862644 |
| 60 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.46503340 |
| 61 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.43043911 |
| 62 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42855803 |
| 63 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.41686793 |
| 64 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.38835053 |
| 65 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.37756850 |
| 66 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.36781650 |
| 67 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.36251068 |
| 68 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.35937369 |
| 69 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.34936529 |
| 70 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.34125953 |
| 71 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.31150996 |
| 72 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.30885605 |
| 73 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.30349960 |
| 74 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.29579981 |
| 75 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.26961024 |
| 76 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26924462 |
| 77 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.26855113 |
| 78 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.25524703 |
| 79 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.25430409 |
| 80 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.24474081 |
| 81 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.23743753 |
| 82 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.23391199 |
| 83 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.21961727 |
| 84 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.21439405 |
| 85 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.20989962 |
| 86 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.20291324 |
| 87 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.20258984 |
| 88 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.20147030 |
| 89 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.17923292 |
| 90 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.14611086 |
| 91 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.14312992 |
| 92 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.13968049 |
| 93 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.13724496 |
| 94 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.11907393 |
| 95 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.11537022 |
| 96 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.10329689 |
| 97 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.10060422 |
| 98 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.09992761 |
| 99 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.09458901 |
| 100 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.08154718 |
| 101 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.07670491 |
| 102 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.07616939 |
| 103 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.05484405 |
| 104 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.04067095 |
| 105 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.03378655 |
| 106 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.01850485 |
| 107 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.01336958 |
| 108 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.00794190 |
| 109 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.00046426 |
| 110 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.99779239 |
| 111 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.99626978 |
| 112 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.99495022 |
| 113 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.98865288 |
| 114 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.98702732 |
| 115 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.95988098 |
| 116 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.95481936 |
| 117 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95329036 |
| 118 | MAF_26560356_Chip-Seq_TH2_Human | 0.94162355 |
| 119 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.92385074 |
| 120 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.92348494 |
| 121 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.91418867 |
| 122 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.91125913 |
| 123 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.89865934 |
| 124 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.88803499 |
| 125 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.88744698 |
| 126 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.88349888 |
| 127 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.87633618 |
| 128 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.87108406 |
| 129 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.87044176 |
| 130 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.86890990 |
| 131 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.86003779 |
| 132 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.85167318 |
| 133 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.82647273 |
| 134 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81046498 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002396_abnormal_hematopoietic_system | 3.45547503 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.10803616 |
| 3 | MP0003763_abnormal_thymus_physiology | 2.93383574 |
| 4 | MP0010094_abnormal_chromosome_stability | 2.87675393 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 2.84123618 |
| 6 | MP0005671_abnormal_response_to | 2.69357168 |
| 7 | MP0000372_irregular_coat_pigmentation | 2.56175678 |
| 8 | MP0010352_gastrointestinal_tract_polyps | 2.54456308 |
| 9 | MP0000685_abnormal_immune_system | 2.53715379 |
| 10 | MP0003693_abnormal_embryo_hatching | 2.47032752 |
| 11 | MP0003718_maternal_effect | 2.41708320 |
| 12 | MP0006054_spinal_hemorrhage | 2.38788682 |
| 13 | MP0002166_altered_tumor_susceptibility | 2.37778768 |
| 14 | MP0008057_abnormal_DNA_replication | 2.32038873 |
| 15 | MP0001800_abnormal_humoral_immune | 2.30414199 |
| 16 | MP0004957_abnormal_blastocyst_morpholog | 2.30257207 |
| 17 | MP0003077_abnormal_cell_cycle | 2.29693249 |
| 18 | MP0009697_abnormal_copulation | 2.27062684 |
| 19 | MP0002398_abnormal_bone_marrow | 2.26319573 |
| 20 | MP0004808_abnormal_hematopoietic_stem | 2.17935760 |
| 21 | MP0003300_gastrointestinal_ulcer | 2.13854301 |
| 22 | MP0000703_abnormal_thymus_morphology | 2.06438088 |
| 23 | MP0002420_abnormal_adaptive_immunity | 2.03091952 |
| 24 | MP0002452_abnormal_antigen_presenting | 2.01322642 |
| 25 | MP0003111_abnormal_nucleus_morphology | 2.00344053 |
| 26 | MP0001819_abnormal_immune_cell | 1.98422219 |
| 27 | MP0005387_immune_system_phenotype | 1.97422428 |
| 28 | MP0001790_abnormal_immune_system | 1.97422428 |
| 29 | MP0008007_abnormal_cellular_replicative | 1.96808219 |
| 30 | MP0000689_abnormal_spleen_morphology | 1.95760393 |
| 31 | MP0002722_abnormal_immune_system | 1.94785160 |
| 32 | MP0000490_abnormal_crypts_of | 1.94345645 |
| 33 | MP0000716_abnormal_immune_system | 1.91963190 |
| 34 | MP0002723_abnormal_immune_serum | 1.90769444 |
| 35 | MP0002006_tumorigenesis | 1.88532490 |
| 36 | MP0009333_abnormal_splenocyte_physiolog | 1.87729663 |
| 37 | MP0005000_abnormal_immune_tolerance | 1.86241535 |
| 38 | MP0001881_abnormal_mammary_gland | 1.86091345 |
| 39 | MP0009785_altered_susceptibility_to | 1.77433226 |
| 40 | MP0002429_abnormal_blood_cell | 1.73903339 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.72769318 |
| 42 | MP0010307_abnormal_tumor_latency | 1.72261878 |
| 43 | MP0010234_abnormal_vibrissa_follicle | 1.66796343 |
| 44 | MP0005025_abnormal_response_to | 1.66703249 |
| 45 | MP0003436_decreased_susceptibility_to | 1.65285349 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.62981947 |
| 47 | MP0001545_abnormal_hematopoietic_system | 1.62981947 |
| 48 | MP0003950_abnormal_plasma_membrane | 1.62523001 |
| 49 | MP0002405_respiratory_system_inflammati | 1.60479208 |
| 50 | MP0002019_abnormal_tumor_incidence | 1.49691683 |
| 51 | MP0005464_abnormal_platelet_physiology | 1.49347736 |
| 52 | MP0006036_abnormal_mitochondrial_physio | 1.46675221 |
| 53 | MP0000858_altered_metastatic_potential | 1.45189553 |
| 54 | MP0002148_abnormal_hypersensitivity_rea | 1.44139905 |
| 55 | MP0004947_skin_inflammation | 1.40949142 |
| 56 | MP0002419_abnormal_innate_immunity | 1.40720448 |
| 57 | MP0003186_abnormal_redox_activity | 1.38891206 |
| 58 | MP0001873_stomach_inflammation | 1.37663852 |
| 59 | MP0002009_preneoplasia | 1.36014088 |
| 60 | MP0000350_abnormal_cell_proliferation | 1.35106800 |
| 61 | MP0005408_hypopigmentation | 1.33988272 |
| 62 | MP0000465_gastrointestinal_hemorrhage | 1.32130735 |
| 63 | MP0000358_abnormal_cell_content/ | 1.31557774 |
| 64 | MP0001730_embryonic_growth_arrest | 1.27394074 |
| 65 | MP0003724_increased_susceptibility_to | 1.25699478 |
| 66 | MP0001845_abnormal_inflammatory_respons | 1.25013364 |
| 67 | MP0008058_abnormal_DNA_repair | 1.23917237 |
| 68 | MP0001661_extended_life_span | 1.22949304 |
| 69 | MP0001853_heart_inflammation | 1.18245605 |
| 70 | MP0002163_abnormal_gland_morphology | 1.17734296 |
| 71 | MP0003866_abnormal_defecation | 1.17332816 |
| 72 | MP0002132_abnormal_respiratory_system | 1.16932458 |
| 73 | MP0005174_abnormal_tail_pigmentation | 1.15567122 |
| 74 | MP0009278_abnormal_bone_marrow | 1.12820281 |
| 75 | MP0000627_abnormal_mammary_gland | 1.12680747 |
| 76 | MP0008995_early_reproductive_senescence | 1.10664799 |
| 77 | MP0003448_altered_tumor_morphology | 1.09066382 |
| 78 | MP0006035_abnormal_mitochondrial_morpho | 1.08005316 |
| 79 | MP0002095_abnormal_skin_pigmentation | 1.07877971 |
| 80 | MP0005023_abnormal_wound_healing | 1.06131557 |
| 81 | MP0003303_peritoneal_inflammation | 1.03352347 |
| 82 | MP0006082_CNS_inflammation | 1.02448251 |
| 83 | MP0000313_abnormal_cell_death | 1.02295585 |
| 84 | MP0005058_abnormal_lysosome_morphology | 1.01371219 |
| 85 | MP0008877_abnormal_DNA_methylation | 1.00674073 |
| 86 | MP0002160_abnormal_reproductive_system | 1.00014763 |
| 87 | MP0005395_other_phenotype | 0.97555024 |
| 88 | MP0008875_abnormal_xenobiotic_pharmacok | 0.96487294 |
| 89 | MP0002933_joint_inflammation | 0.96348230 |
| 90 | MP0003566_abnormal_cell_adhesion | 0.96094118 |
| 91 | MP0001929_abnormal_gametogenesis | 0.95667258 |
| 92 | MP0005076_abnormal_cell_differentiation | 0.95602723 |
| 93 | MP0002877_abnormal_melanocyte_morpholog | 0.93991829 |
| 94 | MP0008932_abnormal_embryonic_tissue | 0.91995170 |
| 95 | MP0003172_abnormal_lysosome_physiology | 0.91706824 |
| 96 | MP0005379_endocrine/exocrine_gland_phen | 0.90685947 |
| 97 | MP0002210_abnormal_sex_determination | 0.90524586 |
| 98 | MP0001216_abnormal_epidermal_layer | 0.85641902 |
| 99 | MP0002086_abnormal_extraembryonic_tissu | 0.85579678 |
| 100 | MP0001915_intracranial_hemorrhage | 0.85432178 |
| 101 | MP0005501_abnormal_skin_physiology | 0.85147118 |
| 102 | MP0001145_abnormal_male_reproductive | 0.84786080 |
| 103 | MP0002080_prenatal_lethality | 0.84716219 |
| 104 | MP0000477_abnormal_intestine_morphology | 0.84022357 |
| 105 | MP0001697_abnormal_embryo_size | 0.83673175 |
| 106 | MP0000015_abnormal_ear_pigmentation | 0.83384547 |
| 107 | MP0005389_reproductive_system_phenotype | 0.82090878 |
| 108 | MP0003984_embryonic_growth_retardation | 0.81750803 |
| 109 | MP0008469_abnormal_protein_level | 0.81568060 |
| 110 | MP0003567_abnormal_fetal_cardiomyocyte | 0.81468764 |
| 111 | MP0000653_abnormal_sex_gland | 0.81159334 |
| 112 | MP0002088_abnormal_embryonic_growth/wei | 0.79574692 |
| 113 | MP0001958_emphysema | 0.79552409 |
| 114 | MP0001764_abnormal_homeostasis | 0.79316265 |
| 115 | MP0001727_abnormal_embryo_implantation | 0.78686490 |
| 116 | MP0005384_cellular_phenotype | 0.78128486 |
| 117 | MP0001119_abnormal_female_reproductive | 0.77806216 |
| 118 | MP0003943_abnormal_hepatobiliary_system | 0.76047975 |
| 119 | MP0005380_embryogenesis_phenotype | 0.75827343 |
| 120 | MP0001672_abnormal_embryogenesis/_devel | 0.75827343 |
| 121 | MP0005075_abnormal_melanosome_morpholog | 0.74455771 |
| 122 | MP0002060_abnormal_skin_morphology | 0.74393167 |
| 123 | MP0010678_abnormal_skin_adnexa | 0.74132524 |
| 124 | MP0005647_abnormal_sex_gland | 0.74027068 |
| 125 | MP0004147_increased_porphyrin_level | 0.73494666 |
| 126 | MP0001849_ear_inflammation | 0.73386904 |
| 127 | MP0002796_impaired_skin_barrier | 0.72362200 |
| 128 | MP0001533_abnormal_skeleton_physiology | 0.71826757 |
| 129 | MP0003279_aneurysm | 0.71364763 |
| 130 | MP0005220_abnormal_exocrine_pancreas | 0.71337945 |
| 131 | MP0000383_abnormal_hair_follicle | 0.70433534 |
| 132 | MP0003786_premature_aging | 0.70383436 |
| 133 | MP0003941_abnormal_skin_development | 0.69271543 |
| 134 | MP0000371_diluted_coat_color | 0.68738851 |
| 135 | MP0005621_abnormal_cell_physiology | 0.67935339 |
| 136 | MP0001919_abnormal_reproductive_system | 0.66585774 |
| 137 | MP0008004_abnormal_stomach_pH | 0.66428984 |
| 138 | MP0003453_abnormal_keratinocyte_physiol | 0.65581856 |
| 139 | MP0003699_abnormal_female_reproductive | 0.64759759 |
| 140 | MP0004197_abnormal_fetal_growth/weight/ | 0.64509190 |
| 141 | MP0000613_abnormal_salivary_gland | 0.64198162 |
| 142 | MP0002136_abnormal_kidney_physiology | 0.62870732 |
| 143 | MP0003828_pulmonary_edema | 0.61046232 |
| 144 | MP0003705_abnormal_hypodermis_morpholog | 0.61034198 |
| 145 | MP0004782_abnormal_surfactant_physiolog | 0.60399517 |
| 146 | MP0008873_increased_physiological_sensi | 0.58840317 |
| 147 | MP0002085_abnormal_embryonic_tissue | 0.58678606 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 5.47490255 |
| 2 | T lymphocytopenia (HP:0005403) | 4.64802919 |
| 3 | Abnormality of T cell number (HP:0011839) | 4.37895982 |
| 4 | Recurrent viral infections (HP:0004429) | 4.22110549 |
| 5 | B lymphocytopenia (HP:0010976) | 4.15624628 |
| 6 | Abnormality of B cell number (HP:0010975) | 4.15624628 |
| 7 | IgM deficiency (HP:0002850) | 4.12816205 |
| 8 | Abnormality of the preputium (HP:0100587) | 3.93663611 |
| 9 | Panhypogammaglobulinemia (HP:0003139) | 3.74202464 |
| 10 | Thrombocytosis (HP:0001894) | 3.70712655 |
| 11 | Reticulocytopenia (HP:0001896) | 3.70221562 |
| 12 | Abnormality of T cells (HP:0002843) | 3.62463672 |
| 13 | Chronic otitis media (HP:0000389) | 3.57634731 |
| 14 | Recurrent bronchitis (HP:0002837) | 3.51755492 |
| 15 | Meckel diverticulum (HP:0002245) | 3.34304362 |
| 16 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 3.29707771 |
| 17 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.27209041 |
| 18 | Abnormality of glycolysis (HP:0004366) | 3.19518549 |
| 19 | Abnormality of the ileum (HP:0001549) | 3.15746473 |
| 20 | Interstitial pulmonary disease (HP:0006530) | 3.14558424 |
| 21 | Small intestinal stenosis (HP:0012848) | 3.13053608 |
| 22 | Duodenal stenosis (HP:0100867) | 3.13053608 |
| 23 | Hypoplasia of the thymus (HP:0000778) | 3.07265353 |
| 24 | IgG deficiency (HP:0004315) | 3.06079004 |
| 25 | Microvesicular hepatic steatosis (HP:0001414) | 3.05931811 |
| 26 | Cholecystitis (HP:0001082) | 3.05109736 |
| 27 | Abnormal gallbladder physiology (HP:0012438) | 3.05109736 |
| 28 | Thyroiditis (HP:0100646) | 3.03964615 |
| 29 | Agnosia (HP:0010524) | 2.97945579 |
| 30 | Myositis (HP:0100614) | 2.94098096 |
| 31 | Severe combined immunodeficiency (HP:0004430) | 2.93624273 |
| 32 | Clubbing of toes (HP:0100760) | 2.93157681 |
| 33 | Combined immunodeficiency (HP:0005387) | 2.91675873 |
| 34 | Cellulitis (HP:0100658) | 2.91576039 |
| 35 | Aplastic anemia (HP:0001915) | 2.90208937 |
| 36 | Recurrent fungal infections (HP:0002841) | 2.90047391 |
| 37 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.88995553 |
| 38 | Colon cancer (HP:0003003) | 2.82539640 |
| 39 | Lymphoma (HP:0002665) | 2.79647046 |
| 40 | Eosinophilia (HP:0001880) | 2.78586629 |
| 41 | Basal cell carcinoma (HP:0002671) | 2.77110794 |
| 42 | Birth length less than 3rd percentile (HP:0003561) | 2.76962837 |
| 43 | Increased hepatocellular lipid droplets (HP:0006565) | 2.75299439 |
| 44 | Abnormality of methionine metabolism (HP:0010901) | 2.74838768 |
| 45 | Abnormal number of erythroid precursors (HP:0012131) | 2.74625956 |
| 46 | Papilledema (HP:0001085) | 2.74220949 |
| 47 | Abnormality of T cell physiology (HP:0011840) | 2.73650652 |
| 48 | Prostate neoplasm (HP:0100787) | 2.73081009 |
| 49 | Meningitis (HP:0001287) | 2.62813282 |
| 50 | Lymphopenia (HP:0001888) | 2.61459167 |
| 51 | IgA deficiency (HP:0002720) | 2.59175028 |
| 52 | Agammaglobulinemia (HP:0004432) | 2.58947893 |
| 53 | Granulocytopenia (HP:0001913) | 2.56784391 |
| 54 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.56635305 |
| 55 | Increased serum pyruvate (HP:0003542) | 2.55475735 |
| 56 | Petechiae (HP:0000967) | 2.54730591 |
| 57 | Papilloma (HP:0012740) | 2.52676338 |
| 58 | Verrucae (HP:0200043) | 2.52676338 |
| 59 | Breast carcinoma (HP:0003002) | 2.50659222 |
| 60 | Duplicated collecting system (HP:0000081) | 2.49884866 |
| 61 | Pancytopenia (HP:0001876) | 2.48862340 |
| 62 | Hypoplasia of the uterus (HP:0000013) | 2.47940166 |
| 63 | Cutaneous melanoma (HP:0012056) | 2.46259524 |
| 64 | Amaurosis fugax (HP:0100576) | 2.41764372 |
| 65 | Increased CSF lactate (HP:0002490) | 2.40688121 |
| 66 | Poikiloderma (HP:0001029) | 2.38406726 |
| 67 | Type I transferrin isoform profile (HP:0003642) | 2.36030823 |
| 68 | Hypoproteinemia (HP:0003075) | 2.35636922 |
| 69 | Increased serum lactate (HP:0002151) | 2.34086339 |
| 70 | Inflammation of the large intestine (HP:0002037) | 2.34074282 |
| 71 | Gastrointestinal inflammation (HP:0004386) | 2.33829249 |
| 72 | Osteomyelitis (HP:0002754) | 2.32708552 |
| 73 | Lipid accumulation in hepatocytes (HP:0006561) | 2.31490746 |
| 74 | Sparse eyelashes (HP:0000653) | 2.28350421 |
| 75 | Abnormality of the fingertips (HP:0001211) | 2.27742569 |
| 76 | Abnormality of the duodenum (HP:0002246) | 2.27275445 |
| 77 | Hepatocellular necrosis (HP:0001404) | 2.26385972 |
| 78 | Hepatic necrosis (HP:0002605) | 2.24347276 |
| 79 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.24127439 |
| 80 | Reduced antithrombin III activity (HP:0001976) | 2.23942292 |
| 81 | Autoimmune thrombocytopenia (HP:0001973) | 2.23312374 |
| 82 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.21846469 |
| 83 | Hematochezia (HP:0002573) | 2.19533364 |
| 84 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.18890197 |
| 85 | Osteolytic defects of the hand bones (HP:0009699) | 2.18890197 |
| 86 | Abnormality of the carotid arteries (HP:0005344) | 2.16821154 |
| 87 | Testicular atrophy (HP:0000029) | 2.15746928 |
| 88 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.15510773 |
| 89 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.13661031 |
| 90 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.13472948 |
| 91 | Recurrent abscess formation (HP:0002722) | 2.13106021 |
| 92 | Aortic aneurysm (HP:0004942) | 2.12228988 |
| 93 | Eczematoid dermatitis (HP:0000976) | 2.12134297 |
| 94 | Abnormality of the prostate (HP:0008775) | 2.11221417 |
| 95 | Embryonal renal neoplasm (HP:0011794) | 2.10380094 |
| 96 | Mitochondrial inheritance (HP:0001427) | 2.10232447 |
| 97 | Abnormality of the renal collecting system (HP:0004742) | 2.10138014 |
| 98 | Increased density of long bones (HP:0006392) | 2.09870560 |
| 99 | Acute myeloid leukemia (HP:0004808) | 2.09792307 |
| 100 | Absent thumb (HP:0009777) | 2.08961654 |
| 101 | Ependymoma (HP:0002888) | 2.08751088 |
| 102 | Bicuspid aortic valve (HP:0001647) | 2.07278781 |
| 103 | Ureteral duplication (HP:0000073) | 2.06206402 |
| 104 | Acute encephalopathy (HP:0006846) | 2.05945273 |
| 105 | Neoplasm of the adrenal gland (HP:0100631) | 2.03421499 |
| 106 | Medulloblastoma (HP:0002885) | 2.03403105 |
| 107 | Myelodysplasia (HP:0002863) | 2.02412415 |
| 108 | Sloping forehead (HP:0000340) | 2.02374414 |
| 109 | Abnormality of eosinophils (HP:0001879) | 2.02332854 |
| 110 | Melanoma (HP:0002861) | 2.01962576 |
| 111 | Sensory axonal neuropathy (HP:0003390) | 2.01418056 |
| 112 | Abnormal glycosylation (HP:0012345) | 2.00823203 |
| 113 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.00823203 |
| 114 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.00823203 |
| 115 | Abnormal protein glycosylation (HP:0012346) | 2.00823203 |
| 116 | Abnormal platelet volume (HP:0011876) | 2.00803225 |
| 117 | Cafe-au-lait spot (HP:0000957) | 2.00264233 |
| 118 | Spontaneous hematomas (HP:0007420) | 2.00020049 |
| 119 | Cerebral edema (HP:0002181) | 1.99578962 |
| 120 | Abnormal platelet function (HP:0011869) | 1.99345633 |
| 121 | Impaired platelet aggregation (HP:0003540) | 1.99345633 |
| 122 | Pallor (HP:0000980) | 1.99260599 |
| 123 | Nasal polyposis (HP:0100582) | 1.98797093 |
| 124 | Gastrointestinal stroma tumor (HP:0100723) | 1.96635803 |
| 125 | Conjunctival hamartoma (HP:0100780) | 1.96481591 |
| 126 | Megaloblastic anemia (HP:0001889) | 1.96319536 |
| 127 | Abnormal spermatogenesis (HP:0008669) | 1.95605876 |
| 128 | Premature ovarian failure (HP:0008209) | 1.95423771 |
| 129 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.95324895 |
| 130 | Renal Fanconi syndrome (HP:0001994) | 1.95173155 |
| 131 | Pustule (HP:0200039) | 1.94927071 |
| 132 | Colitis (HP:0002583) | 1.94782640 |
| 133 | Posterior subcapsular cataract (HP:0007787) | 1.94577364 |
| 134 | Leukocytosis (HP:0001974) | 1.93367504 |
| 135 | Lactic acidosis (HP:0003128) | 1.93308702 |
| 136 | 11 pairs of ribs (HP:0000878) | 1.92527089 |
| 137 | Acute necrotizing encephalopathy (HP:0006965) | 1.91158170 |
| 138 | Vasculitis (HP:0002633) | 1.89909104 |
| 139 | Hypokinesia (HP:0002375) | 1.89360430 |
| 140 | Volvulus (HP:0002580) | 1.89186028 |
| 141 | Chronic diarrhea (HP:0002028) | 1.89097226 |
| 142 | Recurrent bacterial skin infections (HP:0005406) | 1.88775618 |
| 143 | High pitched voice (HP:0001620) | 1.88494693 |
| 144 | Entropion (HP:0000621) | 1.87729220 |
| 145 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.87482428 |
| 146 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.87482428 |
| 147 | Single umbilical artery (HP:0001195) | 1.87482428 |
| 148 | Bronchitis (HP:0012387) | 1.86879918 |
| 149 | Neoplasm of the colon (HP:0100273) | 1.86240368 |
| 150 | Autoimmune hemolytic anemia (HP:0001890) | 1.85787368 |
| 151 | Degeneration of anterior horn cells (HP:0002398) | 1.85769780 |
| 152 | Abnormality of the anterior horn cell (HP:0006802) | 1.85769780 |
| 153 | Short middle phalanx of the 5th finger (HP:0004220) | 1.85488665 |
| 154 | Abnormality of the nasal mucosa (HP:0000433) | 1.85092916 |
| 155 | Spondylolisthesis (HP:0003302) | 1.84708833 |
| 156 | Abnormality of DNA repair (HP:0003254) | 1.84043572 |
| 157 | Abnormal lung lobation (HP:0002101) | 1.82931884 |
| 158 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.82556475 |
| 159 | Abnormality of chromosome stability (HP:0003220) | 1.82465979 |
| 160 | Subacute progressive viral hepatitis (HP:0006572) | 1.82116855 |
| 161 | Abnormality of the umbilical cord (HP:0010881) | 1.81252251 |
| 162 | Skin ulcer (HP:0200042) | 1.81086860 |
| 163 | Ulnar bowing (HP:0003031) | 1.79827623 |
| 164 | Biliary tract neoplasm (HP:0100574) | 1.78790899 |
| 165 | Secondary amenorrhea (HP:0000869) | 1.78648683 |
| 166 | Macrocytic anemia (HP:0001972) | 1.78618261 |
| 167 | Gout (HP:0001997) | 1.78214835 |
| 168 | Encephalitis (HP:0002383) | 1.77435243 |
| 169 | Chromsome breakage (HP:0040012) | 1.77432485 |
| 170 | Increased intramyocellular lipid droplets (HP:0012240) | 1.76255791 |
| 171 | Gonadotropin excess (HP:0000837) | 1.75745863 |
| 172 | Persistence of primary teeth (HP:0006335) | 1.75661158 |
| 173 | Dyschromatopsia (HP:0007641) | 1.75541549 |
| 174 | Neoplasm of the adrenal cortex (HP:0100641) | 1.75328674 |
| 175 | Cerebral aneurysm (HP:0004944) | 1.75247831 |
| 176 | Multiple enchondromatosis (HP:0005701) | 1.74752770 |
| 177 | Increased nuchal translucency (HP:0010880) | 1.73878086 |
| 178 | Arteriovenous malformation (HP:0100026) | 1.73817918 |
| 179 | Progressive macrocephaly (HP:0004481) | 1.73802221 |
| 180 | Squamous cell carcinoma (HP:0002860) | 1.72556611 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.00925909 |
| 2 | VRK2 | 3.12852541 |
| 3 | EEF2K | 3.07059365 |
| 4 | PKN2 | 2.96341073 |
| 5 | STK10 | 2.89976717 |
| 6 | FLT3 | 2.88083703 |
| 7 | CDC7 | 2.71827903 |
| 8 | NUAK1 | 2.45852911 |
| 9 | PBK | 2.29137115 |
| 10 | MAP3K10 | 2.27643680 |
| 11 | ZAP70 | 2.23825536 |
| 12 | LRRK2 | 2.14719751 |
| 13 | TXK | 2.10931014 |
| 14 | SCYL2 | 2.04490498 |
| 15 | ZAK | 2.01935729 |
| 16 | TGFBR2 | 2.00170189 |
| 17 | PLK4 | 1.99694042 |
| 18 | RPS6KB2 | 1.97303132 |
| 19 | CSF1R | 1.95036872 |
| 20 | GRK6 | 1.94618715 |
| 21 | TRIM28 | 1.85125007 |
| 22 | ITK | 1.70915676 |
| 23 | BTK | 1.70460362 |
| 24 | EIF2AK2 | 1.65953174 |
| 25 | TSSK6 | 1.62585922 |
| 26 | NEK2 | 1.62186478 |
| 27 | TYK2 | 1.59327902 |
| 28 | TAF1 | 1.59113682 |
| 29 | MST1R | 1.58099872 |
| 30 | KIT | 1.57277302 |
| 31 | EIF2AK3 | 1.54177533 |
| 32 | PASK | 1.52526394 |
| 33 | NME2 | 1.52424829 |
| 34 | JAK3 | 1.48403254 |
| 35 | WEE1 | 1.47188800 |
| 36 | BUB1 | 1.41533392 |
| 37 | RPS6KA4 | 1.39635613 |
| 38 | MST4 | 1.39056072 |
| 39 | ERBB3 | 1.37551435 |
| 40 | TEC | 1.34469492 |
| 41 | SMG1 | 1.33799958 |
| 42 | SYK | 1.32458544 |
| 43 | TGFBR1 | 1.32292109 |
| 44 | BMPR2 | 1.32003459 |
| 45 | EIF2AK1 | 1.30522503 |
| 46 | MAP3K8 | 1.23726166 |
| 47 | CHEK2 | 1.23089561 |
| 48 | CLK1 | 1.18505042 |
| 49 | PDK2 | 1.17759745 |
| 50 | PAK4 | 1.17644439 |
| 51 | CDK6 | 1.17229869 |
| 52 | CDK4 | 1.15398722 |
| 53 | TESK2 | 1.13420642 |
| 54 | DAPK1 | 1.12556519 |
| 55 | STK4 | 1.11267660 |
| 56 | ATR | 1.10606650 |
| 57 | MKNK2 | 1.10094585 |
| 58 | STK39 | 1.09363117 |
| 59 | LCK | 1.07925856 |
| 60 | BRSK2 | 1.04322682 |
| 61 | CDK12 | 1.03358602 |
| 62 | MAP3K14 | 0.99816887 |
| 63 | NEK1 | 0.99041848 |
| 64 | AURKB | 0.97056744 |
| 65 | MAP2K3 | 0.95964581 |
| 66 | STK16 | 0.94690933 |
| 67 | BCKDK | 0.91086693 |
| 68 | PIM1 | 0.90646130 |
| 69 | VRK1 | 0.89858190 |
| 70 | SIK3 | 0.82859533 |
| 71 | ACVR1B | 0.82604046 |
| 72 | FGFR3 | 0.80431728 |
| 73 | SRPK1 | 0.78762202 |
| 74 | LYN | 0.77992547 |
| 75 | HCK | 0.77765536 |
| 76 | CSK | 0.77329556 |
| 77 | MAPKAPK5 | 0.76141396 |
| 78 | TRIB3 | 0.76049921 |
| 79 | TRPM7 | 0.74904433 |
| 80 | BLK | 0.74068973 |
| 81 | FGFR4 | 0.73788813 |
| 82 | TLK1 | 0.71945531 |
| 83 | TESK1 | 0.71348354 |
| 84 | MAP3K12 | 0.71239663 |
| 85 | CCNB1 | 0.71124835 |
| 86 | MELK | 0.69327055 |
| 87 | OXSR1 | 0.68424038 |
| 88 | PTK6 | 0.67995442 |
| 89 | TBK1 | 0.67309622 |
| 90 | ERN1 | 0.67293729 |
| 91 | CDK7 | 0.66268197 |
| 92 | HIPK2 | 0.63912625 |
| 93 | TTK | 0.63645259 |
| 94 | PRKCI | 0.62229957 |
| 95 | FGFR1 | 0.61046351 |
| 96 | AURKA | 0.60995658 |
| 97 | CHEK1 | 0.60887477 |
| 98 | NEK9 | 0.60769376 |
| 99 | ALK | 0.60059844 |
| 100 | ILK | 0.58635079 |
| 101 | JAK1 | 0.58045583 |
| 102 | MKNK1 | 0.55810439 |
| 103 | PRKCQ | 0.54783155 |
| 104 | BCR | 0.54730418 |
| 105 | FRK | 0.54696561 |
| 106 | IRAK3 | 0.54302420 |
| 107 | PAK2 | 0.53915021 |
| 108 | PLK1 | 0.53053422 |
| 109 | MAPKAPK3 | 0.52656199 |
| 110 | JAK2 | 0.51999585 |
| 111 | NME1 | 0.51772648 |
| 112 | PLK2 | 0.51763215 |
| 113 | IKBKB | 0.50853076 |
| 114 | TTN | 0.50576105 |
| 115 | CSNK2A2 | 0.50192707 |
| 116 | PIM2 | 0.48108587 |
| 117 | MAPKAPK2 | 0.45941021 |
| 118 | CSNK2A1 | 0.45675813 |
| 119 | IKBKE | 0.45356523 |
| 120 | BRD4 | 0.43670763 |
| 121 | ATM | 0.43642890 |
| 122 | RAF1 | 0.43589314 |
| 123 | BRSK1 | 0.43573710 |
| 124 | CSNK1G3 | 0.43499610 |
| 125 | FGFR2 | 0.43216220 |
| 126 | NLK | 0.42000269 |
| 127 | MATK | 0.41209406 |
| 128 | BRAF | 0.40474781 |
| 129 | PLK3 | 0.40044837 |
| 130 | PDGFRB | 0.37863833 |
| 131 | ERBB4 | 0.37543321 |
| 132 | CDK1 | 0.36665968 |
| 133 | CDK2 | 0.35495797 |
| 134 | CDK8 | 0.34741253 |
| 135 | TAOK3 | 0.34349015 |
| 136 | STK24 | 0.33972744 |
| 137 | PAK1 | 0.33690679 |
| 138 | MAPK11 | 0.33579787 |
| 139 | DYRK3 | 0.33376626 |
| 140 | STK3 | 0.33151402 |
| 141 | CDK9 | 0.33025261 |
| 142 | EPHA2 | 0.32189809 |
| 143 | KDR | 0.31752191 |
| 144 | RPS6KA5 | 0.30906835 |
| 145 | BMPR1B | 0.29048070 |
| 146 | FER | 0.26901427 |
| 147 | CSNK1G1 | 0.26740188 |
| 148 | CSNK1A1L | 0.26205102 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.67941750 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 3.70580405 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.50316146 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 2.94340491 |
| 5 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.66046154 |
| 6 | Base excision repair_Homo sapiens_hsa03410 | 2.44363375 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.44079547 |
| 8 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.26138595 |
| 9 | Protein export_Homo sapiens_hsa03060 | 2.21831587 |
| 10 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.05458652 |
| 11 | Spliceosome_Homo sapiens_hsa03040 | 2.03409836 |
| 12 | Homologous recombination_Homo sapiens_hsa03440 | 1.91197287 |
| 13 | Cell cycle_Homo sapiens_hsa04110 | 1.90638378 |
| 14 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.85955455 |
| 15 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.78737325 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.77906617 |
| 17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.69516462 |
| 18 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.68004929 |
| 19 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.64868793 |
| 20 | RNA transport_Homo sapiens_hsa03013 | 1.61664055 |
| 21 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.52252138 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.50270602 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.48665393 |
| 24 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.48268862 |
| 25 | Basal transcription factors_Homo sapiens_hsa03022 | 1.48047029 |
| 26 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.46962243 |
| 27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.45186870 |
| 28 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.42858344 |
| 29 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.39934624 |
| 30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.39434395 |
| 31 | Leishmaniasis_Homo sapiens_hsa05140 | 1.39057981 |
| 32 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.36148822 |
| 33 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.34465845 |
| 34 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.33638913 |
| 35 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.33389009 |
| 36 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.31967741 |
| 37 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.29318664 |
| 38 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.29247138 |
| 39 | * Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.24132661 |
| 40 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.23940646 |
| 41 | Allograft rejection_Homo sapiens_hsa05330 | 1.19967315 |
| 42 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.16829153 |
| 43 | * Carbon metabolism_Homo sapiens_hsa01200 | 1.16205940 |
| 44 | RNA degradation_Homo sapiens_hsa03018 | 1.15810678 |
| 45 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.14434029 |
| 46 | Proteasome_Homo sapiens_hsa03050 | 1.14248853 |
| 47 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.13222686 |
| 48 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.12688072 |
| 49 | Viral myocarditis_Homo sapiens_hsa05416 | 1.10433975 |
| 50 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.09461061 |
| 51 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.08173997 |
| 52 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.07893253 |
| 53 | Legionellosis_Homo sapiens_hsa05134 | 1.07891318 |
| 54 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.06032543 |
| 55 | Thyroid cancer_Homo sapiens_hsa05216 | 1.04462499 |
| 56 | Apoptosis_Homo sapiens_hsa04210 | 1.03736627 |
| 57 | Hepatitis B_Homo sapiens_hsa05161 | 1.03209688 |
| 58 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.02747926 |
| 59 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.01069930 |
| 60 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.00846547 |
| 61 | HTLV-I infection_Homo sapiens_hsa05166 | 1.00202042 |
| 62 | * Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.99626258 |
| 63 | Shigellosis_Homo sapiens_hsa05131 | 0.96847871 |
| 64 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.96172570 |
| 65 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.94409284 |
| 66 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.94235380 |
| 67 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.93528021 |
| 68 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.92372709 |
| 69 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.92121167 |
| 70 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.91316809 |
| 71 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.91230997 |
| 72 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.91177751 |
| 73 | RNA polymerase_Homo sapiens_hsa03020 | 0.89857833 |
| 74 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.88393002 |
| 75 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.88124589 |
| 76 | Colorectal cancer_Homo sapiens_hsa05210 | 0.86037267 |
| 77 | Parkinsons disease_Homo sapiens_hsa05012 | 0.85823368 |
| 78 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.85743414 |
| 79 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.84934102 |
| 80 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.84490965 |
| 81 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.83105349 |
| 82 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.83069575 |
| 83 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.80915688 |
| 84 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.79995704 |
| 85 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.78827426 |
| 86 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.78746862 |
| 87 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.78654273 |
| 88 | Other glycan degradation_Homo sapiens_hsa00511 | 0.77282119 |
| 89 | Pertussis_Homo sapiens_hsa05133 | 0.76863878 |
| 90 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.75808438 |
| 91 | Influenza A_Homo sapiens_hsa05164 | 0.74795559 |
| 92 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.70866655 |
| 93 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.70020482 |
| 94 | Platelet activation_Homo sapiens_hsa04611 | 0.69076479 |
| 95 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.68822597 |
| 96 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.67855466 |
| 97 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.67030914 |
| 98 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.63044456 |
| 99 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.62829269 |
| 100 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.62800637 |
| 101 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.61634697 |
| 102 | Tuberculosis_Homo sapiens_hsa05152 | 0.60973673 |
| 103 | Huntingtons disease_Homo sapiens_hsa05016 | 0.60024395 |
| 104 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.59314756 |
| 105 | Asthma_Homo sapiens_hsa05310 | 0.57661348 |
| 106 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.54474763 |
| 107 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.51535889 |
| 108 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.51231938 |
| 109 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.50548247 |
| 110 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49760898 |
| 111 | Galactose metabolism_Homo sapiens_hsa00052 | 0.49756434 |
| 112 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.49443715 |
| 113 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.49185521 |
| 114 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.48252611 |
| 115 | Malaria_Homo sapiens_hsa05144 | 0.48240011 |
| 116 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.45830028 |
| 117 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.45008463 |
| 118 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.43929638 |
| 119 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.42685222 |
| 120 | Lysosome_Homo sapiens_hsa04142 | 0.42394353 |
| 121 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.41541051 |
| 122 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.40857283 |
| 123 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.40444194 |
| 124 | Sulfur relay system_Homo sapiens_hsa04122 | 0.40106153 |
| 125 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.39274600 |
| 126 | Hepatitis C_Homo sapiens_hsa05160 | 0.38122308 |
| 127 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.37589239 |
| 128 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.36895792 |
| 129 | Adherens junction_Homo sapiens_hsa04520 | 0.35755288 |
| 130 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.35057585 |
| 131 | Salmonella infection_Homo sapiens_hsa05132 | 0.34530654 |
| 132 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.33366634 |
| 133 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.33118667 |
| 134 | * Purine metabolism_Homo sapiens_hsa00230 | 0.33113044 |
| 135 | Prostate cancer_Homo sapiens_hsa05215 | 0.33008697 |
| 136 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.32945850 |
| 137 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.32809279 |
| 138 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.32798813 |
| 139 | Pathways in cancer_Homo sapiens_hsa05200 | 0.32147910 |
| 140 | Alzheimers disease_Homo sapiens_hsa05010 | 0.31950051 |
| 141 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.31112288 |
| 142 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.30736099 |
| 143 | Peroxisome_Homo sapiens_hsa04146 | 0.30598972 |
| 144 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.30502805 |
| 145 | Bladder cancer_Homo sapiens_hsa05219 | 0.29085654 |
| 146 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.28139371 |
| 147 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.27870567 |
| 148 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.27780050 |
| 149 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.26193398 |
| 150 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.26070937 |
| 151 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.20280489 |
| 152 | Lysine degradation_Homo sapiens_hsa00310 | 0.18700872 |
| 153 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.18172915 |

